Report quality without making unsupported public claims
Use internal findings to decide whether the Bolton service is ready for greater demand. Include unfinished actions, supplier limitations, and the experience of patients who needed another route. A favourable headline measure should not conceal a clinically important unresolved problem.
If findings are used publicly, explain the population, period, and limits of the evidence. Apply MHRA medicines-advertising guidance to treatment-related promotion. A quality review or patient quotation does not automatically support a broad claim about medicine outcomes or remove advertising restrictions. MHRA: advertise your medicines
Avoid presenting the existence of a review process as proof that every encounter is safe or that a regulator has approved the service. Name professional reviewers only where their role and consent are established. This guide does not supply a legal or clinical endorsement.
Repeat the relevant review after meaningful changes to staff, categories, or partners. The operating evidence should remain connected to the service patients are currently using. Expand when the team understands both its strengths and its unresolved work, with an accountable plan for improving the latter.